Serum ECP levels and methacholine challenge in infants with recurrent wheezing

Annals of Allergy, Asthma and Immunology

Volumn 89, Issue 5, 2002, Pages 498-502

  Reichenbach, Janine ^a   Jarisch, Andrea ^a   Khan, Saima ^a   Hömberg, Miriam ^a   Bez, Christina ^a   Zielen, Stefan ^a  

^a UNIVERSITY HOSPITAL FRANKFURT   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

EOSINOPHIL CATIONIC PROTEIN; METHACHOLINE;

ARTICLE; ASTHMA; BRONCHUS HYPERREACTIVITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DISASTER; DISEASE MARKER; FEMALE; HUMAN; INFANT; INFLAMMATION; LUNG FUNCTION; MAJOR CLINICAL STUDY; MALE; MEDIATOR RELEASE; PATHOGENESIS; PRESCHOOL CHILD; PRIORITY JOURNAL; PROVOCATION TEST; RECURRENT DISEASE; TREATMENT PLANNING; WHEEZING;

EID: 0036879473     PISSN: 10811206     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1081-1206(10)62088-1     Document Type: Article

References (29)

1. 2-agonist, terbutaline, with inhaled corticosteroids, budesonide, in newly detected asthma. N Engl J Med 1991;325:388-392.
2. Haahtela T, Jarvinen M, Kava T, et al. Effect of reducing or discontinuing inhaled budesonide in patients with mild asthma. N Engl J Med 1991;331:700-705.
3. Selroos O, Pietinhalo A, Lofroos AB, Riska H. Effect of early versus late intervention with inhaled corticosteroids in asthma. Chest 1995;108:1228-1234.
4. Koller DY, Herouy Y, Gotz M, et al. Clinical value of monitoring eosinophil activity in asthma. Arch Dis Child 1995;73:413-417.
5. Koller DY, Wojnarowski C, Herkner KR, et al. High levels of eosinophilic cationic protein in wheezing infants predict the development of asthma. J Allergy Clin Immunol 1997;99:752-756.
6. Reijonen TM, Korppi M. One-year follow-up of young children hospitalized for wheezing: the influence of early anti-inflammatory therapy and risk factors for subsequent wheezing and asthma. Pediatr Pulmonol 1998;26:113-119.
7. Bousquet J, Chanez P, Lacoste JY, et al. Eosinophilic inflammation in asthma. N Engl J Med 1990;323:1033-1039.
8. Roquet A, Hallden G, Ihre E, et al. Eosinophil activity markers in peripheral blood have high predictive value for bronchial hyperreactivity in patients with suspected mild asthma. Allergy 1996;51:482-488.
9. Koller DY, Halmerbauer G, Frischer T, Roithner B. Assessment of eosinophil granule proteins in various body fluids: is there a relation to clinical variables in childhood asthma? Clin Exp Allergy 1999;29:786-793.
10. Ferdousi HA, Dreborg S. Asthma, bronchial reactivity and mediator release in children with birch pollinosis. ECP and EPX levels are not related to bronchial hyperreactivity. Clin Exp Allergy 1997;27:530-539.
11. Ferguson AC, Vaughan R, Brown H, Curtis C. Evaluation of serum eosinophilic cationic protein as a marker of disease activity in chronic asthma. J Allergy Clin Immunol 1995;95:23-28.
12. Oddera S, Silvestri M, Penna R, et al. Airway eosinophilic inflammation and bronchial hyperresponsiveness after allergen inhalation challenge in asthma. Lung 1998;176:237-247.
13. Yoshikawa T, Shoji S, Fujii T, et al. Severity of exercise-induced bronchoconstriction is related to airway eosinophilic inflammation in patients with asthma. Eur Respir J 1998;12:879-884.
14. Fujisawa T, Tereda A, Atsuta J, et al. Clinical utility of serum levels of eosinophil cationic protein (ECP) for monitoring and predicting clinical course in childhood asthma. Clin Exp Allergy 1998;28:19-25.
15. Benoist MR, Brouard JJ, Rufin P, et al. Ability of new lung function tests to assess methacholine-induced airway obstruction in infants. Pediatr Pulmonol 1994;18:308-316.
16. Stocks J. Lung function testing in infants. Pediatr Pulmonol Suppl 1999;18:14-20.
17. Jarisch A, Sach G, Reichenbach J, et al. Safety and tolerability of methacholine challenge test in young infants with suspected asthma. Am J Respir Crit Care Med 1999;159:A505.
18. Bisgaard H, Klug B. Lung function measurement in awake young children. Eur Respir J 1995;8:2067-2075.
19. 20, and exacerbations. Respir Med 1994;88:613-621.
20. Niimi A, Amitani R, Suzuki K, et al. Serum eosinophil cationic protein as a marker of eosinophilic inflammation in asthma. Clin Exp Allergy 1998;28:233-240.
21. Nishikawa M, Suzuki S, Miyazawa N, et al. Serum level of eosinophil cationic protein in patients with chronic cough: relationship to blood eosinophils and airway hyperresponsiveness. J Asthma 1998;35:219-224.
22. Rao R, Frederick JM, Enander I, et al. Airway function correlates with circulating eosinophil, but not mast cell, markers of inflammation in childhood asthma. Clin Exp Allergy 1996;26:789-793.
23. Avital A, Springer C, Bar-Yishay E, Godfrey S. Adenosine, methacholine and exercise challenges in children with asthma or pediatric chronic obstructive pulmonary disease. Thorax 1995;50:511-516.
24. Lødrup Carlsen KC, Halvorsen R, Ahlstedt S, Carlsen KH. Eosinophil cationic protein and tidal flow volume loops in children 0-2 years of age. Eur Respir J 1995;8:1148-1154.
25. Crimi E, Spanevello A, Neri M, et al. Dissociation between airway inflammation and airway hyperresponsiveness in allergic asthma. Am J Respir Crit Care Med 1998;157:4-9.
26. Wiggs BR, Bosken C, Pare PD, et al. A model of airway narrowing in asthma and in chronic obstructive pulmonary disease. Ann Rev Respir Dis 1991;145:1251-1258.
27. Delacourt C, Benoist MR, Waernessyckle S, et al. Repeatability of lung function tests during methacholine challenge in wheezy infants. Thorax 1998;53:933-938.
28. Prehn A, Seger RA, Faber J, et al. The relationship of serumeosinophil cationic protein and eosinophil count to disease activity in children with bronchial asthma. Pediatr Allergy Immunol 1998;9:197-203.
29. Martinez FD, Wright AL, Taussig LM, et al. The Group of Health Medical Associates. Asthma and wheezing in the first six years of life. N Engl J Med 1995;332:113-118.